@parkevtatevosiancfa9544
YouTube
Avg. Quality
74
Success Rate
8.57
Analysis
315
Correct
27
Fail
89
Pending
186
Ineffective
0
Total Quality
Score
If You Had Traded on This Analysis…
Correct
LLY
Long Entry
748.4000
2025-09-16
04:54 UTC
Target
800.0000
In 2 Weeks
Fail
700.0000
Risk/Reward
1 : 1
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
Final PnL
6.89%
P/L: —
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
The video identifies three undervalued healthcare stocks: Eli Lilly (LLY), Novo Nordisk (NVO), and Pfizer (PFE). Eli Lilly is trading at a forward price to earnings of 27, Novo Nordisk at 15, and Pfizer at 8.5. Pfizer increased its revenue from 49 billion to 64 billion, spiking in 2020 due to the COVID vaccine, but has since crashed. Eli Lilly and Novo Nordisk have compounded annual growth rates of 11% and 12.8% respectively, outperforming Pfizer because of weight loss and diabetes treatments with upcoming oral pill versions. The video identifies the stocks as potential opportunities for long term investors.
